Total Payments
$21,513
2024 Payments
$2,398
Companies
40
Transactions
741
Medicare Patients
3,256
Medicare Billing
$730,359
Payment Breakdown by Category
Food & Beverage$15,945 (74.1%)
Consulting$4,978 (23.1%)
Education$589.95 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,945 | 713 | 74.1% |
| Consulting Fee | $4,978 | 3 | 23.1% |
| Education | $589.95 | 25 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $5,538 | 32 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $2,819 | 84 | $0 (2024) |
| CSL Behring | $1,984 | 94 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,306 | 68 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,218 | 55 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,057 | 37 | $0 (2024) |
| PFIZER INC. | $1,019 | 55 | $0 (2024) |
| GENZYME CORPORATION | $881.09 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $576.71 | 29 | $0 (2023) |
| ABBVIE INC. | $561.27 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,398 | 98 | Takeda Pharmaceuticals U.S.A., Inc. ($478.17) |
| 2023 | $2,492 | 108 | AstraZeneca Pharmaceuticals LP ($468.18) |
| 2022 | $3,035 | 122 | CSL Behring ($364.99) |
| 2021 | $2,126 | 88 | AstraZeneca Pharmaceuticals LP ($599.58) |
| 2020 | $1,123 | 61 | CSL Behring ($247.01) |
| 2019 | $6,600 | 85 | Shire North American Group Inc ($5,112) |
| 2018 | $1,913 | 93 | AstraZeneca Pharmaceuticals LP ($478.58) |
| 2017 | $1,825 | 86 | AstraZeneca Pharmaceuticals LP ($327.40) |
All Payment Transactions
741 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: BIOLOGIC | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $99.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/23/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Immunology | ||||||
| 11/21/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Immunology | ||||||
| 11/20/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $20.86 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $31.10 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $105.84 | General |
| 10/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: Immunology | ||||||
| 09/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Immunology | ||||||
| 09/18/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 09/18/2024 | Cycle Pharmaceuticals Inc | Sajazir (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 726 | 4,392 | $254,889 | $85,194 |
| 2022 | 12 | 695 | 3,038 | $232,324 | $81,070 |
| 2021 | 16 | 890 | 9,246 | $839,239 | $265,999 |
| 2020 | 16 | 945 | 10,938 | $990,033 | $298,096 |
Total Patients
3,256
Total Services
27,614
Medicare Billing
$730,359
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 325 | 593 | $108,519 | $39,453 | 36.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 23 | 200 | $25,800 | $11,101 | 43.0% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 25 | 755 | $24,915 | $8,530 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 81 | $21,870 | $7,986 | 36.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 43 | 2,146 | $36,482 | $6,817 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 54 | $14,652 | $4,748 | 32.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $7,055 | $2,174 | 30.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 14 | 198 | $5,940 | $1,691 | 28.5% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 17 | 182 | $4,004 | $1,310 | 32.7% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 46 | 51 | $2,397 | $708.05 | 29.5% |
| 89190 | Nasal smear for eosinophils (allergy related white blood cells) | Office | 2023 | 79 | 96 | $2,400 | $540.93 | 22.5% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 13 | 19 | $855.00 | $133.76 | 15.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 310 | 568 | $103,944 | $37,317 | 35.9% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 30 | 274 | $35,346 | $16,248 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 86 | $23,220 | $8,016 | 34.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 26 | 430 | $14,190 | $4,468 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $13,695 | $3,987 | 29.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 20 | 1,063 | $18,071 | $3,506 | 19.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 57 | 61 | $6,649 | $2,714 | 40.8% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 22 | 232 | $5,104 | $1,505 | 29.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 15 | 164 | $4,920 | $1,354 | 27.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,276 | $900.48 | 27.5% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 45 | 47 | $2,209 | $665.55 | 30.1% |
| 89190 | Nasal smear for eosinophils (allergy related white blood cells) | Office | 2022 | 56 | 68 | $1,700 | $389.94 | 22.9% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2021 | 11 | 5,370 | $537,000 | $160,694 | 29.9% |
About Dr. Mark Minor, MD
Dr. Mark Minor, MD is a Allergy healthcare provider based in Melbourne, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982609657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Minor, MD has received a total of $21,513 in payments from pharmaceutical and medical device companies, with $2,398 received in 2024. These payments were reported across 741 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($15,945).
As a Medicare-enrolled provider, Minor has provided services to 3,256 Medicare beneficiaries, totaling 27,614 services with total Medicare billing of $730,359. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy
- Location Melbourne, FL
- Active Since 06/17/2005
- Last Updated 03/19/2025
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1982609657
Products in Payments
- TAKHZYRO (Biological) $5,165
- DUPIXENT (Biological) $1,593
- CUVITRU (Biological) $986.17
- FASENRA (Biological) $771.81
- Hizentra (Biological) $690.67
- Haegarda (Biological) $641.67
- NUCALA (Biological) $602.36
- Xolair (Biological) $529.97
- RINVOQ (Biological) $514.26
- SPIRIVA RESPIMAT (Drug) $513.73
- RUCONEST (Biological) $493.09
- TEZSPIRE (Biological) $484.99
- TRELEGY ELLIPTA (Drug) $435.18
- FASENRA (Drug) $405.18
- PANZYGA (Biological) $370.06
- SYMBICORT (Drug) $351.42
- ORLADEYO (Drug) $329.70
- DUPIXENT (Drug) $304.13
- XOLAIR (Biological) $297.38
- AYVAKIT (Drug) $285.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.